The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Characteristics of SonoVue™
Abstract
The advances made by ultrasonography in the last decade, in parallel with the development of ultrasound contrast agents, have opened a wide range of potential breakthroughs in the field of ultrasound imaging. SonoVue™ is a new echocontrast agent made of microbubbles stabilized by phospholipids and containing sulphur hexafluoride (SF6), an innocuous gas. The suspension of the microbubbles is stable over the time following reconstitution. The bubble concentration of SonoVue™ is between 100 and 500 million per ml. The mean bubble diameter is 2.5 μm and more than 90% of the bubbles are smaller than 8 μm. Following intravenous injection, the bubble suspension is submitted to pressure increases. SF 6, a high molecular weight gas with low solubility in water, was selected since laboratory tests showed that it confers to the bubbles a good resistance to pressure changes as those that occur in the left ventricle, in the pulmonary capillaries, or in the coronary circulation. The high bubble concentration, combined with a favorable size distribution profile, provides SonoVue™ with a strong echogenicity. SonoVue™ shows a peak in the backscatter coefficient at about 3 MHz. With regard to the gas contained in the bubbles, its pharmacokinetics have been assessed during a study in human volunteers. Following intravenous administration of 0.3 ml/kg of SonoVue™ (i.e., approximately ten times the imaging dose), the blood level curve showed a distribution half‐life of about 1 minute and an elimination half‐life of about 6 minutes. More than 80% of the administered gas is exhaled via the lungs after 11 minutes. Extensive studies in animals and humans have confirmed the outstanding safety profile of this second generation contrast agent and its capability in providing a clinically useful ultrasound signal enhancement for the evaluation of cardiac function and extracardiac vessel abnormalities. Thanks to the long persistence of SF 6 microbubbles, SonoVue™ is also potentially useful in the assessment of myocardial perfusion, as well as microcirculatory disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MOREL, D. R., SCHWIEGER, I., HOHN, L., TERRETTAZ, J., LLULL, J. B., CORNIOLEY, Y. A., & SCHNEIDER, M. (2000) · Investigative Radiology · doi:10.1097/00004424-200001000-00009 · Cited by 254
Self-citation
Cited by
Ultrasound Microbubble Contrast Agents: Fundamentals and Application to Gene and Drug Delivery
Ferrara, K., Pollard, R., & Borden, M. (2007) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095852 · Cited by 1,288
Schutt, E. G., Klein, D. H., Mattrey, R. M., & Riess, J. G. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200550 · Cited by 543
Dimcevski, G., Kotopoulis, S., Bjånes, T., Hoem, D., Schjøtt, J., Gjertsen, B. T., Biermann, M., Molven, A., Sorbye, H., McCormack, E., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.10.007 · Cited by 434
Boissenot, T., Bordat, A., Fattal, E., & Tsapis, N. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.09.026 · Cited by 264
EPA and DHA Fatty Acids Induce a Remodeling of Tumor Vasculature and Potentiate Docetaxel Activity
Goupille, C., Vibet, S., Frank, P. G., & Mahéo, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144965 · Cited by 17
Metadata
- Authors
- SCHNEIDER, M.
- Venue
- Echocardiography
- Publisher
- Wiley
- Published
- 1999-10
- Volume
- 16
- Issue
- s1
- Pages
- 743-746
- ISSN
- 0742-2822 (ISSN-L)
- 1540-8175
- OpenAlex
- W2151761801
- Cited by
- 264
- References
- 1
- FWCI
- 3.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characteristics of SonoVue™. https://app.cochat.ai/papers/10.1111/j.1540-8175.1999.tb00144.x
- The paper
- SCHNEIDER, M. (1999). Characteristics of SonoVue™. Echocardiography. https://doi.org/10.1111/j.1540-8175.1999.tb00144.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.